Poor Numeracy as a Limiting Factor for Successful Treatment of Type 1 Diabetes Mellitus (T1DM) Patients on Continuous Subcutaneous Insulin Infusion (CSII)

被引：0
|
作者：
Patrakeeva, Evgenya M.
Romanova, Natalia N.
Zalevskaya, Alsu G.
Shlyakhto, Evgenya V.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
996-P
引用
收藏
页码：A255 / A255
页数：1
相关论文
共 50 条
  • [41] Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service
    Rodrigues, IAS
    Reid, HA
    Ismail, K
    Amiel, SA
    DIABETIC MEDICINE, 2005, 22 (07) : 842 - 849
  • [42] A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
    King, Allen B.
    Kuroda, Akio
    Matsuhisa, Munehide
    Hobbs, Todd
    CURRENT DIABETES REPORTS, 2016, 16 (09)
  • [43] A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
    Allen B. King
    Akio Kuroda
    Munehide Matsuhisa
    Todd Hobbs
    Current Diabetes Reports, 2016, 16
  • [44] An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes
    Schiaffini, R
    Ciampalini, P
    Spera, S
    Cappa, M
    Crinó, A
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (04) : 347 - 352
  • [45] Defining insulin needs by means of continuous subcutaneous insulin infusion (CSII) in type I diabetes mellitus.
    Petraroli, G
    Dani, F
    Grassi, G
    Maghenzani, G
    Monge, L
    Pinach, S
    Benaduce, E
    Carta, Q
    DIABETOLOGIA, 1997, 40 : 1312 - 1312
  • [46] Improvement of retinopathy in type 1 diabetic patients (T1D) treated with continuous subcutaneous insulin infusion (CSII)
    Aragona, M
    Giannarelli, R
    Coppelli, A
    Palumbo, F
    Pancani, F
    Del Prato, S
    Marchetti, P
    DIABETES, 2003, 52 : A101 - A102
  • [47] COMPATIBILITY AND SAFETY OF ULTRA RAPID LISPRO (URLI) WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN PATIENTS WITH TYPE 1 DIABETES (T1D)
    Bode, B.
    Liu, R.
    Hardy, T.
    Ignaut, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A66 - A67
  • [48] Continious subcutaneous insulin infusion (CSII) treatment in children and adolescents with type 1 diabetes in Siberia
    Osokina, Irina V.
    Strelnikov, Gregory U.
    HORMONE RESEARCH, 2009, 72 : 328 - 329
  • [49] Continuous subcutaneous insulin infusion in older patients with type 1 diabetes
    Siegel-Czarkowski, L
    Herold, KC
    Goland, RS
    DIABETES CARE, 2004, 27 (12) : 3022 - 3023
  • [50] LONG-TERM TREATMENT OF TYPE-I DIABETES-MELLITUS BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    SCHROER, G
    SONNENBERG, GE
    CHANTELAU, E
    BERGER, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) : 38 - 38
12345